Dr. Bill Willmore has been awarded the Early Researcher Award (ERA) from the Ontario Government for his work on Adaptation to Low Oxygen in Cardiovascular Disease. His research is focused on the molecular basis for the adaptation to low oxygen in cardiovascular disease. Cardiac arrest and stroke are the result of clots that block the flow of blood (ischemia) to portions of the heart and brain. During ischemia, cells sense a decrease in oxygen (hypoxia) through a process called protein hydroxylation. Dr. Willmore leads a team of researchers at Carleton University who will examine the role of hydroxylation in ischemic cardiovascular diseases and stroke to better understand how cells recover from ischemic stress & hypoxia.